FFL
EBS icon

Financial Freedom LLC’s Emergent Biosolutions EBS Stock Holding History

Financial Freedom LLC’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-300
Closed -$2.5K – 361
2024
Q3 		$2.5K Hold
300
– – ﹤0.01% 327
2024
Q2 		$2.05K Hold
300
– – ﹤0.01% 340
2024
Q1 		$759 Hold
300
– – ﹤0.01% 350
2023
Q4 		$720 Hold
300
– – ﹤0.01% 347
2023
Q3 		$1.02K Hold
300
– – ﹤0.01% 354
2023
Q2 		$2.21K Hold
300
– – ﹤0.01% 353
2023
Q1 		$3.11K Hold
300
– – ﹤0.01% 338
2022
Q4 		$3.54K Buy
+300
New +$4.64K ﹤0.01% 332

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Financial Freedom LLC's EBS Position: Q4 2024 in Review

Financial Freedom LLC sold out of Emergent Biosolutions (EBS) in Q4 2024, closing a stake of 300 shares — an estimated $2.5K sold.

Financial Freedom LLC first reported a position in EBS in Q4 2022 and held it in 8 quarters. The position peaked at $3.54K in Q4 2022. 156 funds tracked by Wall St. Rank hold EBS as of Q4 2024.

  • Financial Freedom LLC reported no remaining Emergent Biosolutions position as of Q4 2024 after selling out during the quarter.
  • Financial Freedom LLC sold 300 Emergent Biosolutions shares in Q4 2024, an estimated $2.5K.
  • Financial Freedom LLC first reported a position in Emergent Biosolutions in Q4 2022 and held it in 8 quarters.
  • Financial Freedom LLC's Emergent Biosolutions position peaked at $3.54K in Q4 2022.
  • 156 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2024.

Based on Financial Freedom LLC's 13F filing for Q4 2024, filed 16 Jan 2025.